+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Immunotherapy Drugs Market Size, Share & Trends Analysis Report by Drug Type, Indication, Region, and Segment Forecasts, 2026-2033- Product Image
Immunotherapy Drugs Market Size, Share & Trends Analysis Report by Drug Type, Indication, Region, and Segment Forecasts, 2026-2033- Product Image
New

Immunotherapy Drugs Market Size, Share & Trends Analysis Report by Drug Type, Indication, Region, and Segment Forecasts, 2026-2033

  • PDF Icon

    Report

  • 100 Pages
  • January 2026
  • Region: Global
  • Grand View Research
  • ID: 6040935
REQUEST CUSTOMIZATION
Description Jump to:
The global immunotherapy drugs market size was estimated at USD 285.73 billion in 2025 and is expected to reach USD 675.98 billion by 2033, growing at a CAGR of 11.41% from 2026 to 2033. This market is primarily driven by the rising incidence of chronic diseases globally.

This market was driven by the rising global burden of cancer and chronic diseases, including autoimmune and inflammatory disorders, alongside the growing limitations of conventional treatments such as chemotherapy and radiation therapy. These constraints had accelerated the shift toward immunotherapy because of its targeted mechanism of action and improved patient outcomes. For instance, February 2025, the World Health Organization reported that cancer was responsible for nearly 10 million deaths in 2020, accounting for almost one in six deaths globally. Breast cancer recorded 2.26 million cases, lung cancer 2.21 million, and colorectal cancer 1.93 million, while lung cancer caused 1.80 million deaths. The organization also estimated around 400,000 childhood cancer cases annually and noted that 30 percent of cancers in low and lower middle income countries were infection related, reinforcing demand for advanced immunotherapies.

Technological advancements and robust research activity play a critical role in driving the immunotherapy drugs market forward. Significant progress in immuno-oncology, particularly in immune checkpoint inhibitors, monoclonal antibodies, and cell-based therapies such as CAR-T, has transformed cancer treatment paradigms. These therapies have demonstrated strong efficacy across multiple solid tumors and hematological malignancies, leading to expanding clinical indications. Pharmaceutical and biotechnology companies are investing heavily in research and development to improve therapeutic effectiveness, reduce adverse effects, and develop next-generation immunotherapies. Strategic collaborations, mergers, and acquisitions are also accelerating innovation and pipeline expansion. Moreover, favorable regulatory frameworks, fast-track approvals, and orphan drug designations in major markets are enabling faster commercialization of novel immunotherapy drugs, thereby contributing significantly to market growth.

Beyond oncology, the immunotherapy drugs market was supported by expanding applications and improving healthcare infrastructure worldwide, which broadened overall market potential. Immunotherapies were increasingly explored for autoimmune diseases, infectious diseases, and rare genetic disorders, enabling wider clinical adoption. In developed regions, strong reimbursement systems, higher healthcare spending, and access to advanced diagnostic facilities facilitated routine use of immunotherapy drugs. At the same time, emerging economies experienced steady growth due to improvements in healthcare systems, rising medical tourism, and government initiatives aimed at strengthening cancer care delivery. Growing awareness among patients and healthcare providers, coupled with gradual improvements in the affordability of biologic therapies, further supported uptake. Together, these interconnected factors sustained long term growth prospects and continued innovation in the global immunotherapy drugs market.

Global Immunotherapy Drugs Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, the analyst has segmented the global immunotherapy drugs market report based on drug type, indication, and region:

Drug Type Outlook (Revenue, USD Million, 2021-2033)

  • Monoclonal Antibodies
  • Immunomodulator
  • Vaccine
  • Others

Indication Outlook (Revenue, USD Million, 2021-2033)

  • Cancer
  • Autoimmune Diseases
  • Infectious Diseases
  • Others

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa (MEA)

Why You Should Buy This Report

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Immunotherapy Drugs Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Immunotherapy Drugs Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape.
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Immunotherapy Drugs Market: Drug Type Estimates & Trend Analysis
4.1. Drug Type Market Share, 2025 & 2033
4.2. Drug Type Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Drug Type, 2021 to 2033 (USD Million)
4.4. Monoclonal Antibodies
4.4.1. Monoclonal Antibodies Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5. Immunomodulator
4.5.1. Immunomodulator Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.6. Vaccine
4.6.1. Vaccine Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.7. Others
4.7.1. Others Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 5. Immunotherapy Drugs Market: Indication Estimates & Trend Analysis
5.1. Indication Market Share, 2025 & 2033
5.2. Indication Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Drug Type, 2021 to 2033 (USD Million)
5.4. Cancer
5.4.1. Cancer Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.5. Autoimmune Diseases
5.5.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.6. Infectious Diseases
5.6.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.7. Others
5.7.1. Others Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 6. Immunotherapy Drugs Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2025 & 2033
6.2. Regional Market Dashboard
6.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
6.4. North America
6.4.1. North America Immunotherapy Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.2. U.S.
6.4.2.1. Key Country Dynamics
6.4.2.2. Regulatory Framework
6.4.2.3. Competitive Insights
6.4.2.4. U.S. Immunotherapy Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.3. Canada
6.4.3.1. Key Country Dynamics
6.4.3.2. Regulatory Framework
6.4.3.3. Competitive Insights
6.4.3.4. Canada Immunotherapy Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.4. Mexico
6.4.4.1. Key Country Dynamics
6.4.4.2. Regulatory Framework
6.4.4.3. Competitive Insights
6.4.4.4. Mexico Immunotherapy Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5. Europe
6.5.1. Europe Immunotherapy Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.2. UK
6.5.2.1. Key Country Dynamics
6.5.2.2. Regulatory Framework
6.5.2.3. Competitive Insights
6.5.2.4. UK Immunotherapy Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.3. Germany
6.5.3.1. Key Country Dynamics
6.5.3.2. Regulatory Framework
6.5.3.3. Competitive Insights
6.5.3.4. Germany Immunotherapy Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.4. France
6.5.4.1. Key Country Dynamics
6.5.4.2. Regulatory Framework
6.5.4.3. Competitive Insights
6.5.4.4. France Immunotherapy Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.5. Italy
6.5.5.1. Key Country Dynamics
6.5.5.2. Regulatory Framework
6.5.5.3. Competitive Insights
6.5.5.4. Italy Immunotherapy Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.6. Spain
6.5.6.1. Key Country Dynamics
6.5.6.2. Regulatory Framework
6.5.6.3. Competitive Insights
6.5.6.4. Spain Immunotherapy Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.7. Denmark
6.5.7.1. Key Country Dynamics
6.5.7.2. Regulatory Framework
6.5.7.3. Competitive Insights
6.5.7.4. Denmark Immunotherapy Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.8. Sweden
6.5.8.1. Key Country Dynamics
6.5.8.2. Regulatory Framework
6.5.8.3. Competitive Insights
6.5.8.4. Sweden Immunotherapy Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.9. Norway
6.5.9.1. Key Country Dynamics
6.5.9.2. Regulatory Framework
6.5.9.3. Competitive Insights
6.5.9.4. Norway Immunotherapy Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific Immunotherapy Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6.2. Japan
6.6.2.1. Key Country Dynamics
6.6.2.2. Regulatory Framework
6.6.2.3. Competitive Insights
6.6.2.4. Japan Immunotherapy Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Regulatory Framework
6.6.3.3. Competitive Insights
6.6.3.4. China Immunotherapy Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6.4. India
6.6.4.1. Key Country Dynamics
6.6.4.2. Regulatory Framework
6.6.4.3. Competitive Insights
6.6.4.4. India Immunotherapy Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6.5. Thailand
6.6.5.1. Key Country Dynamics
6.6.5.2. Regulatory Framework
6.6.5.3. Competitive Insights
6.6.5.4. Thailand Immunotherapy Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6.6. South Korea
6.6.6.1. Key Country Dynamics
6.6.6.2. Regulatory Framework
6.6.6.3. Competitive Insights
6.6.6.4. South Korea Immunotherapy Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6.7. Australia
6.6.7.1. Key Country Dynamics
6.6.7.2. Regulatory Framework
6.6.7.3. Competitive Insights
6.6.7.4. Australia Immunotherapy Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7. Latin America
6.7.1. Latin America Immunotherapy Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7.2. Brazil
6.7.2.1. Key Country Dynamics
6.7.2.2. Regulatory Framework
6.7.2.3. Competitive Insights
6.7.2.4. Brazil Immunotherapy Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7.3. Argentina
6.7.3.1. Key Country Dynamics
6.7.3.2. Regulatory Framework
6.7.3.3. Competitive Insights
6.7.3.4. Argentina Immunotherapy Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
6.8. Middle East and Africa
6.8.1. Middle East and Africa Immunotherapy Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
6.8.2. South Africa
6.8.2.1. Key Country Dynamics
6.8.2.2. Regulatory Framework
6.8.2.3. Competitive Insights
6.8.2.4. South Africa Immunotherapy Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key Country Dynamics
6.8.3.2. Regulatory Framework
6.8.3.3. Competitive Insights
6.8.3.4. Saudi Arabia Immunotherapy Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
6.8.4. UAE
6.8.4.1. Key Country Dynamics
6.8.4.2. Regulatory Framework
6.8.4.3. Competitive Insights
6.8.4.4. UAE Immunotherapy Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key Country Dynamics
6.8.5.2. Regulatory Framework
6.8.5.3. Competitive Insights
6.8.5.4. Kuwait Immunotherapy Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. Amgen Inc.
7.5.1.1. Participant’s Overview
7.5.1.2. Financial Performance
7.5.1.3. Product Benchmarking
7.5.1.4. Recent Developments/ Strategic Initiatives
7.5.2. Novartis AG
7.5.2.1. Participant’s Overview
7.5.2.2. Financial Performance
7.5.2.3. Product Benchmarking
7.5.2.4. Recent Developments/ Strategic Initiatives
7.5.3. AbbVie Inc.
7.5.3.1. Participant’s Overview
7.5.3.2. Financial Performance
7.5.3.3. Product Benchmarking
7.5.3.4. Recent Developments/ Strategic Initiatives
7.5.4. Pfizer Inc.
7.5.4.1. Participant’s Overview
7.5.4.2. Financial Performance
7.5.4.3. Product Benchmarking
7.5.4.4. Recent Developments/ Strategic Initiatives
7.5.5. F. Hoffmann-La Roche Ltd
7.5.5.1. Participant’s Overview
7.5.5.2. Financial Performance
7.5.5.3. Product Benchmarking
7.5.5.4. Recent Developments/ Strategic Initiatives
7.5.6. Johnson & Johnson Services, Inc.
7.5.6.1. Participant’s Overview
7.5.6.2. Financial Performance
7.5.6.3. Product Benchmarking
7.5.6.4. Recent Developments/ Strategic Initiatives
7.5.7. AstraZeneca
7.5.7.1. Participant’s Overview
7.5.7.2. Financial Performance
7.5.7.3. Product Benchmarking
7.5.7.4. Recent Developments/ Strategic Initiatives
7.5.8. GSK plc.
7.5.8.1. Participant’s Overview
7.5.8.2. Financial Performance
7.5.8.3. Product Benchmarking
7.5.8.4. Recent Developments/ Strategic Initiatives
7.5.9. Sanofi
7.5.9.1. Participant’s Overview
7.5.9.2. Financial Performance
7.5.9.3. Product Benchmarking
7.5.9.4. Recent Developments/ Strategic Initiatives
7.5.10. Bayer AG
7.5.10.1. Participant’s Overview
7.5.10.2. Financial Performance
7.5.10.3. Product Benchmarking
7.5.10.4. Recent Developments/ Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global Immunotherapy Drugs Market, by Region, 2021-2033 (USD Million)
Table 4 Global Immunotherapy Drugs Market, by Drug Type, 2021-2033 (USD Million)
Table 5 Global Immunotherapy Drugs Market, by Indication, 2021-2033 (USD Million)
Table 6 North America Immunotherapy Drugs Market, by Country, 2021-2033 (USD Million)
Table 7 North America Immunotherapy Drugs Market, by Drug Type, 2021-2033 (USD Million)
Table 8 North America Immunotherapy Drugs Market, by Indication, 2021-2033 (USD Million)
Table 9 U.S. Immunotherapy Drugs Market, by Drug Type, 2021-2033 (USD Million)
Table 10 U.S. Immunotherapy Drugs Market, by Indication, 2021-2033 (USD Million)
Table 11 Canada Immunotherapy Drugs Market, by Drug Type, 2021-2033 (USD Million)
Table 12 Canada Immunotherapy Drugs Market, by Indication, 2021-2033 (USD Million)
Table 13 Mexico Immunotherapy Drugs Market, by Drug Type, 2021-2033 (USD Million)
Table 14 Mexico Immunotherapy Drugs Market, by Indication, 2021-2033 (USD Million)
Table 15 Europe Immunotherapy Drugs Market, by Country, 2021-2033 (USD Million)
Table 16 Europe Immunotherapy Drugs Market, by Drug Type, 2021-2033 (USD Million)
Table 17 Europe Immunotherapy Drugs Market, by Indication, 2021-2033 (USD Million)
Table 18 Germany Immunotherapy Drugs Market, by Drug Type, 2021-2033 (USD Million)
Table 19 Germany Immunotherapy Drugs Market, by Indication, 2021-2033 (USD Million)
Table 20 UK Immunotherapy Drugs Market, by Drug Type, 2021-2033 (USD Million)
Table 21 UK Immunotherapy Drugs Market, by Indication, 2021-2033 (USD Million)
Table 22 France Immunotherapy Drugs Market, by Drug Type, 2021-2033 (USD Million)
Table 23 France Immunotherapy Drugs Market, by Indication, 2021-2033 (USD Million)
Table 24 Italy Immunotherapy Drugs Market, by Drug Type, 2021-2033 (USD Million)
Table 25 Italy Immunotherapy Drugs Market, by Indication, 2021-2033 (USD Million)
Table 26 Spain Immunotherapy Drugs Market, by Drug Type, 2021-2033 (USD Million)
Table 27 Spain Immunotherapy Drugs Market, by Indication, 2021-2033 (USD Million)
Table 28 Sweden Immunotherapy Drugs Market, by Drug Type, 2021-2033 (USD Million)
Table 29 Sweden Immunotherapy Drugs Market, by Indication, 2021-2033 (USD Million)
Table 30 Denmark Immunotherapy Drugs Market, by Drug Type, 2021-2033 (USD Million)
Table 31 Denmark Immunotherapy Drugs Market, by Indication, 2021-2033 (USD Million)
Table 32 Norway Immunotherapy Drugs Market, by Drug Type, 2021-2033 (USD Million)
Table 33 Norway Immunotherapy Drugs Market, by Indication, 2021-2033 (USD Million)
Table 34 Asia Pacific Immunotherapy Drugs Market, by Country, 2021-2033 (USD Million)
Table 35 Asia Pacific Immunotherapy Drugs Market, by Drug Type, 2021-2033 (USD Million)
Table 36 Asia Pacific Immunotherapy Drugs Market, by Indication, 2021-2033 (USD Million)
Table 37 China Immunotherapy Drugs Market, by Drug Type, 2021-2033 (USD Million)
Table 38 China Immunotherapy Drugs Market, by Indication, 2021-2033 (USD Million)
Table 39 Japan Immunotherapy Drugs Market, by Drug Type, 2021-2033 (USD Million)
Table 40 Japan Immunotherapy Drugs Market, by Indication, 2021-2033 (USD Million)
Table 41 India Immunotherapy Drugs Market, by Drug Type, 2021-2033 (USD Million)
Table 42 India Immunotherapy Drugs Market, by Indication, 2021-2033 (USD Million)
Table 43 South Korea Immunotherapy Drugs Market, by Drug Type, 2021-2033 (USD Million)
Table 44 South Korea Immunotherapy Drugs Market, by Indication, 2021-2033 (USD Million)
Table 45 Australia Immunotherapy Drugs Market, by Drug Type, 2021-2033 (USD Million)
Table 46 Australia Immunotherapy Drugs Market, by Indication, 2021-2033 (USD Million)
Table 47 Thailand Immunotherapy Drugs Market, by Drug Type, 2021-2033 (USD Million)
Table 48 Thailand Immunotherapy Drugs Market, by Indication, 2021-2033 (USD Million)
Table 49 Latin America Immunotherapy Drugs Market, by Country, 2021-2033 (USD Million)
Table 50 Latin America Immunotherapy Drugs Market, by Drug Type, 2021-2033 (USD Million)
Table 51 Latin America Immunotherapy Drugs Market, by Indication, 2021-2033 (USD Million)
Table 52 Brazil Immunotherapy Drugs Market, by Drug Type, 2021-2033 (USD Million)
Table 53 Brazil Immunotherapy Drugs Market, by Indication, 2021-2033 (USD Million)
Table 54 Argentina Immunotherapy Drugs Market, by Drug Type, 2021-2033 (USD Million)
Table 55 Argentina Immunotherapy Drugs Market, by Indication, 2021-2033 (USD Million)
Table 56 Middle East & Africa Immunotherapy Drugs Market, by Country, 2021-2033 (USD Million)
Table 57 Middle East & Africa Immunotherapy Drugs Market, by Drug Type, 2021-2033 (USD Million)
Table 58 Middle East & Africa Immunotherapy Drugs Market, by Indication, 2021-2033 (USD Million)
Table 59 South Africa Immunotherapy Drugs Market, by Drug Type, 2021-2033 (USD Million)
Table 60 South Africa Immunotherapy Drugs Market, by Indication, 2021-2033 (USD Million)
Table 61 Saudi Arabia Immunotherapy Drugs Market, by Drug Type, 2021-2033 (USD Million)
Table 62 Saudi Arabia Immunotherapy Drugs Market, by Indication, 2021-2033 (USD Million)
Table 63 UAE Immunotherapy Drugs Market, by Drug Type, 2021-2033 (USD Million)
Table 64 UAE Immunotherapy Drugs Market, by Indication, 2021-2033 (USD Million)
Table 65 Kuwait Immunotherapy Drugs Market, by Drug Type, 2021-2033 (USD Million)
Table 66 Kuwait Immunotherapy Drugs Market, by Indication, 2021-2033 (USD Million)
List of Figures
Figure 1 Immunotherapy drugs market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 Market formulation & validation
Figure 8 Market snapshot
Figure 9 Segment outlook (USD Million)
Figure 10 Competitive landscape
Figure 11 Immunotherapy drugs market dynamics
Figure 12 Immunotherapy drugs market: Porter’s five forces analysis
Figure 13 Immunotherapy drugs market: PESTLE analysis
Figure 14 Immunotherapy drugs market: Drug type segment dashboard
Figure 15 Immunotherapy drugs market: Drug type market share analysis, 2025 & 2033
Figure 16 Monoclonal antibodies market, 2021-2033 (USD Million)
Figure 17 Immunomodulator market, 2021-2033 (USD Million)
Figure 18 Vaccine market, 2021-2033 (USD Million)
Figure 19 Others market, 2021-2033 (USD Million)
Figure 20 Immunotherapy drugs market: Indication segment dashboard
Figure 21 Immunotherapy drugs market: Indication market share analysis, 2025 & 2033
Figure 22 Cancer market, 2021-2033 (USD Million)
Figure 23 Autoimmune diseases market, 2021-2033 (USD Million)
Figure 24 Infectious diseases market, 2021-2033 (USD Million)
Figure 25 Others market, 2021-2033 (USD Million)
Figure 26 Immunotherapy drugs market revenue, by region
Figure 27 Regional marketplace: Key takeaways
Figure 28 North America immunotherapy drugs market, 2021-2033 (USD Million)
Figure 29 U.S. country dynamics
Figure 30 U.S. immunotherapy drugs market, 2021-2033 (USD Million)
Figure 31 Canada country dynamics
Figure 32 Canada immunotherapy drugs market, 2021-2033 (USD Million)
Figure 33 Mexico country dynamics
Figure 34 Mexico immunotherapy drugs market, 2021-2033 (USD Million)
Figure 35 Europe immunotherapy drugs market, 2021-2033 (USD Million)
Figure 36 UK country dynamics
Figure 37 UK immunotherapy drugs market, 2021-2033 (USD Million)
Figure 38 Germany country dynamics
Figure 39 Germany immunotherapy drugs market, 2021-2033 (USD Million)
Figure 40 France country dynamics
Figure 41 France immunotherapy drugs market, 2021-2033 (USD Million)
Figure 42 Italy country dynamics
Figure 43 Italy immunotherapy drugs market, 2021-2033 (USD Million)
Figure 44 Spain country dynamics
Figure 45 Spain immunotherapy drugs market, 2021-2033 (USD Million)
Figure 46 Denmark country dynamics
Figure 47 Denmark immunotherapy drugs market, 2021-2033 (USD Million)
Figure 48 Sweden country dynamics
Figure 49 Sweden immunotherapy drugs market, 2021-2033 (USD Million)
Figure 50 Norway country dynamics
Figure 51 Norway immunotherapy drugs market, 2021-2033 (USD Million)
Figure 52 Asia Pacific immunotherapy drugs market, 2021-2033 (USD Million)
Figure 53 Japan country dynamics
Figure 54 Japan immunotherapy drugs market, 2021-2033 (USD Million)
Figure 55 China country dynamics
Figure 56 China immunotherapy drugs market, 2021-2033 (USD Million)
Figure 57 India country dynamics
Figure 58 India immunotherapy drugs market, 2021-2033 (USD Million)
Figure 59 Thailand country dynamics
Figure 60 Thailand immunotherapy drugs market, 2021-2033 (USD Million)
Figure 61 South Korea country dynamics
Figure 62 South Korea immunotherapy drugs market, 2021-2033 (USD Million)
Figure 63 Australia country dynamics
Figure 64 Australia immunotherapy drugs market, 2021-2033 (USD Million)
Figure 65 Latin America immunotherapy drugs market, 2021-2033 (USD Million)
Figure 66 Brazil country dynamics
Figure 67 Brazil immunotherapy drugs market, 2021-2033 (USD Million)
Figure 68 Argentina country dynamics
Figure 69 Argentina immunotherapy drugs market, 2021-2033 (USD Million
Figure 70 MEA immunotherapy drugs market, 2021-2033 (USD Million)
Figure 71 South Africa country dynamics
Figure 72 South Africa immunotherapy drugs market, 2021-2033 (USD Million)
Figure 73 Saudi Arabia country dynamics
Figure 74 Saudi Arabia immunotherapy drugs market, 2021-2033 (USD Million)
Figure 75 UAE country dynamics
Figure 76 UAE immunotherapy drugs market, 2021-2033 (USD Million)
Figure 77 Kuwait country dynamics
Figure 78 Kuwait immunotherapy drugs market, 2021-2033 (USD Million)
Figure 79 Company categorization
Figure 80 Company market position analysis
Figure 81 Strategic framework

Companies Mentioned

The leading players profiled in this Immunotherapy Drugs market report include:
  • Amgen Inc.
  • Novartis AG
  • AbbVie Inc.
  • Pfizer Inc.
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson Services, Inc.
  • AstraZeneca
  • GSK plc.
  • Sanofi
  • Bayer AG

Table Information

Report AttributeDetails
No. of Pages100
PublishedJanuary 2026
Forecast Period2025 - 2033
Estimated Market Value ( USD ) in 2025 $ 285.73 Billion
Forecasted Market Value ( USD ) by 2033 $ 675.98 Billion
Compound Annual Growth Rate11.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Cancer Immunotherapy Market Size, Share & Trends Analysis Report by Product (Monoclonal Antibodies, Immunomodulators), Application, Distribution Channel, End Use, and Region with Growth Forecasts, 2026-2033 - Product Image

Cancer Immunotherapy Market Size, Share & Trends Analysis Report by Product (Monoclonal Antibodies, Immunomodulators), Application, Distribution Channel, End Use, and Region with Growth Forecasts, 2026-2033

  • Report
  • 150 Pages
  • Global
From
Head and Neck Cancer Therapeutics Market Size, Share & Trends Analysis Report by Therapy (Chemotherapy, Immunotherapy), Route of Administration, Distribution Channel (Hospital Pharmacies, Online Pharmacies), and Region with Growth Forecasts, 2026-2033 - Product Image

Head and Neck Cancer Therapeutics Market Size, Share & Trends Analysis Report by Therapy (Chemotherapy, Immunotherapy), Route of Administration, Distribution Channel (Hospital Pharmacies, Online Pharmacies), and Region with Growth Forecasts, 2026-2033

  • Report
  • 150 Pages
  • Global
From
Cancer Immunotherapy Market Size, Share, Trends and Forecast by Therapy Type, Application, End User, and Region, 2025-2033 - Product Image

Cancer Immunotherapy Market Size, Share, Trends and Forecast by Therapy Type, Application, End User, and Region, 2025-2033

  • Report
  • 139 Pages
  • Global
From
Cancer Immunotherapy Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033 - Product Image

Cancer Immunotherapy Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

  • Report
  • 200 Pages
  • Global
From
Immunotherapy Drugs Market (2026 Edition) - Product Image

Immunotherapy Drugs Market (2026 Edition)

  • Report
  • 209 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.